ACTA NEUROPHARMACOLOGICA››2022,Vol. 12››Issue (2): 35-.DOI:10.3969/j.issn.2095-1396.2022.02.007
Previous ArticlesNext Articles
ZHANG Mei,WEI Wei
Online:
Published:
Abstract:
Key words:denosumab,rheumatoid arthritis,osteoporosis
CLC Number:
R593.22
ZHANG Mei, WEI Wei. Denosumab in the Treatment of Rheumatoid Arthritis[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(2): 35-.
Add to citation managerEndNote|Ris|BibTeX
URL:http://actanp.hebeinu.edu.cn/EN/10.3969/j.issn.2095-1396.2022.02.007
http://actanp.hebeinu.edu.cn/EN/Y2022/V12/I2/35